Novartis (NYSE: [[ticker:NVS]]) today unveiled a plan to cut some 2,500 job but—despite an ominously worded reference to to the Novartis Institutes for BioMedical Research, which employs 1,300 people in Cambridge, MA—there will be no Massachusetts jobs lost. This according to the Boston Business Journal‘s Mark Hollmer, who writes that some 300 additional Novartis jobs in the state are safe as well.
Author: Rebecca Zacks
Rebecca is Xconomy's co-founder. She was previously the managing editor of Physician's First Watch, a daily e-newsletter from the publishers of New England Journal of Medicine. Before helping launch First Watch, she spent a decade covering innovation for Technology Review, Scientific American, and Discover Magazine's TV show. In 2005-2006 she was a Knight Science Journalism Fellow at MIT. Rebecca holds a bachelor's degree in biology from Brown University and a master's in science journalism from Boston University.
View all posts by Rebecca Zacks
